Johnson & Johnson MedTech Unveils Cereglide 92 Large-Bore Catheter System for Acute Ischemic Stroke Treatment

Sudden Stroke is Dangerous! This New Catheter May Bring a Turning Point

Did you know? Stroke, commonly known as apoplexy, has become the leading cause of death and disability in adults in China. Among these, acute ischemic stroke is the most common, accounting for approximately 80%. With the intensification of global aging, its incidence rate is still on the rise. Hypertension, hyperlipidemia, and unhealthy living habits are all potential risk factors.

At present, the main methods for treating acute ischemic stroke are intravenous thrombolysis and mechanical thrombectomy, but there are still about 50% Patients after a stroke 3 Months with Disability , which indicates the limitations of existing treatment methods and an urgent need for more effective treatment options. Against this backdrop, Johnson & Johnson Medical (Johnson & Johnson MedTech) Brings Good News, Launches New Large-Bore Stroke Catheter System, Offering New Hope for the Treatment of Acute Ischemic Stroke.

New Product Launch: Cereglide 92 Catheter System

Recently, Johnson & Johnson Medical Technologies (Johnson & Johnson MedTech) Heavily launched the next-generation catheter for treating patients with acute ischemic stroke ——Cereglide 92 Catheter System. This news has drawn widespread attention in the medical field, bringing new hope to many patients suffering from acute ischemic stroke.

Cereglide 92 The design of the catheter system is ingenious,It consists of a 0.92 -inch catheter and the company's Innerglide 9 Delivery auxiliary equipment composition.This combination design is another bold innovation by Johnson & Johnson Medical in the field of stroke treatment, aiming to provide clinicians with a more powerful treatment tool to help them treat patients more accurately and efficiently.

Powerful Functions and Innovative Design

(1) System Composition

‍

Cereglide 92 The design of the catheter system is highly innovative, with its core components including a unique 0.92 Inch catheter, this large-caliber design is not common in similar products, providing a broader space for subsequent treatment operations. . Supporting Innerglide 9 Delivery auxiliary equipment, more like a catheter “Capable Assistant”. It can assist the catheter in moving more smoothly within the patient’s body during the surgical procedure, ensuring the continuity and stability of the entire treatment process. This dual-component combination is like a meticulously choreographed dance, with both parts working together to provide doctors with greater efficiency and precision.‍Therapeutic tools.‍

‍

(II) Functional Highlights

1.Precision-guided interventional device: The accurate guidance of interventional devices to the lesion site is crucial in the treatment of acute ischemic stroke.Cereglide 92 The catheter system is like an experienced navigator, able to guide interventional devices through the complex neurovascular system of a patient. It can skillfully bypass various obstructions in blood vessels, delivering therapeutic instruments precisely to the targeted treatment site, greatly enhancing the accuracy and effectiveness of the treatment. It is akin to finding the correct path in a maze.Cereglide 92 The catheter system allows interventional devices to reach their destination smoothly. “Destination”, providing precise treatment to the affected area.

2.Managing Bleeding Complications and Providing Distal Support: When bleeding complications such as aneurysms occur,Cereglide 92 The large lumen design of the catheter system plays a crucial role. It provides more space, facilitating various procedures by doctors, such as delivering hemostatic materials or performing other necessary treatments. Just like in emergencies, a spacious passage allows rescue supplies to pass through quickly. At the same time, it offers strong support to distal blood vessels, ensuring their stability during treatment. This is similar to pillars in construction that support the entire structure, preventing the blood vessels from collapsing or encountering other issues during treatment and ensuring smooth progress of the procedure.

3.Full Visibility Under FluoroscopyDuring the surgery, the doctor needs to know the position and status of the catheter in real time to make accurate judgments and operations.Cereglide 92 The catheter system has full visibility under fluoroscopy, which brings great convenience to the surgery. Doctors can clearly see the position, direction, and relationship of the catheter with the surrounding tissues within the patient's body through fluoroscopic equipment. It is like lighting a lamp in the darkness, allowing doctors to have an immediate understanding of the catheter’s situation, thereby performing operations more accurately, avoiding unnecessary damage to the surrounding tissues, and improving the safety and success rate of the surgery.

Clinical Significance and Expert Evaluation

1. Clinical Significance

In the treatment of acute ischemic stroke, mechanical thrombectomy is an important therapeutic approach but faces numerous challenges. Among these, access issues are particularly prominent, with approximately 50% Cases of mechanical thrombectomy involve vascular tortuosity and other anatomical challenges. . These challenges are like重重 obstacles on the road, which may not only increase operation time and prolong patients' pain, but also hinder the smooth progress of treatment and affect the treatment outcome. And Cereglide 92 The emergence of the catheter system is like opening up an unobstructed path for doctors. “Green Channel”, effectively solving these access challenges. It can help doctors perform surgeries more quickly and smoothly, improve the success rate of surgeries, bring better treatment outcomes for patients, and greatly enhance the treatment level of acute ischemic stroke.

(2) Expert Evaluation

Chairman of the Department of Neurosurgery at the Hackensack Meridian Neuroscience Institute, Kennedy University Medical Center, and Co-Chair of the Stroke and Neurovascular Program Brian Jankowitz Doctor, as Cereglide 92 And Innerglide 9 The early user of this product has a profound experience and high evaluation of it. He pointed out that this extra-large caliber catheter system is like a capable assistant, which helps to provide M1 The rapid and seamless access allows doctors to reach the lesion site more quickly. At the same time, it also has the advantage of flow control, acting like a precise flow regulator that enables doctors to better control blood flow during surgery, rapidly reperfuse patients, and restore the smooth flow of their blood vessels. This advantage extends the benefits of next-generation stroke technology to more patients, benefiting more individuals suffering from acute ischemic stroke and bringing them hope for recovery.Brian Jankowitz Doctor's evaluation fully reflectsCereglide 92 The Significant Advantages and Important Value of Catheter Systems in Practical Applications.

Market Layout and Business Dynamics

(1) Product Launch

Currently,Cereglide 92 The catheter system has been put into use across the United States, meaning that patients and doctors in the U.S. are among the first to experience the therapeutic benefits offered by this innovative product. This move is undoubtedly an important step for Johnson & Johnson Medical Technologies in the stroke treatment market. By promoting it in the U.S. market, clinical feedback can be quickly collected to further optimize the product's performance. At the same time, this lays the foundation for its future market expansion in other regions around the globe. With Johnson & Johnson's brand influence in the medical field and its extensive sales network, there is good reason to believe that, in the near future,Cereglide 92 Catheter system will go global, benefiting more patients with acute ischemic stroke in other countries.

(II) Business Dynamics

Notably, just one day before the launch of the new product, media reports surfaced that Johnson & Johnson plans to acquire for more than 10 Johnson & Johnson Sells Its Stroke Business for $XX Billion. This news has sparked widespread market attention and speculation, and there seems to be a complex relationship between the launch of new products and the plan to sell the business. From a business strategy perspective, launching new products may be Johnson & Johnson's way of enhancing the overall value of its stroke business, allowing it to achieve a higher valuation at the time of sale. It’s like carefully packaging a product to make it more appealing in the market. By showcasing the latest technological achievements and innovative products, Johnson & Johnson can demonstrate the growth potential and technical strength of its stroke business to potential buyers, attract more buyers, and increase the likelihood and price of a successful transaction.

For the market, this news may trigger a series of chain reactions. If Johnson & Johnson successfully sells its stroke business, the market landscape may undergo significant changes. The new buyer may restructure and plan the business, introducing new development ideas and competitive strategies. This may prompt other competitors to reassess their positioning in the stroke treatment field, increase R&D investment and marketing efforts to address potential market changes. The entire stroke treatment market may usher in a new wave of competition and innovation, ultimately benefiting a large number of patients.

Summary and Outlook

Cereglide 92 The launch of the catheter system is undoubtedly a significant breakthrough in the field of acute ischemic stroke treatment. With its unique design and powerful functionality, it provides doctors with a more effective treatment tool, which is expected to significantly improve patient outcomes and quality of life. As this product enters the U.S. market and potentially expands globally in the future, there is good reason to expect it to play a crucial role in stroke treatment, bringing hope to many patients.

At the same time, the launch of this new product also allows us to witness the power of continuous innovation in the field of medical technology. In the future, we believe there will be more likeCereglide 92 The emergence of innovative products such as catheter systems is driving the continuous advancement of stroke treatment technology, making stroke no longer a threat to human health. “Top Killer”, bringing more hope for life and possibilities of recovery to patients worldwide.